These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1942719)

  • 1. Factors influencing the survival of patients with cervical carcinoma.
    Nasseri KK; Kimler BF; Hassenein RS; Gemer LS
    Kans Med; 1991 Sep; 92(9):217-21. PubMed ID: 1942719
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors that affect survival after the treatment of early stage cervical carcinoma.
    Atasii T; Aksu MF; Cetinkaya MB
    Int Surg; 2000; 85(2):147-51. PubMed ID: 11071333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cervical cancer].
    Sekiba K; Nakagiri Y; Handa M; Yuasa T
    Nihon Rinsho; 1993 Jan; 51 Suppl():793-8. PubMed ID: 8459615
    [No Abstract]   [Full Text] [Related]  

  • 5. The prognostic implications of anaemia in the outcome of patients with early stages of uterine cervix carcinoma.
    Martin-Loeches M; Ortí RM; Asins E; Llixiona J
    Arch Gynecol Obstet; 2003 Jan; 267(3):121-5. PubMed ID: 12552320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.
    Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognosis of patients with stage Ib-IIb node-positive cervical carcinoma].
    Cheng X; Cai SM; Li ZT; Tang MQ; Xue MQ; Zang RY
    Ai Zheng; 2003 Nov; 22(11):1219-23. PubMed ID: 14613657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cervical carcinoma in the T1b stage. Therapy, complications and prognosis].
    Liebenstein J; Noack EJ; Hettenbach A; Bauknecht H
    Zentralbl Gynakol; 1984; 106(3):160-9. PubMed ID: 6702346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic prognostic factors in early stage cervical carcinoma.
    Benda JA
    J Natl Cancer Inst Monogr; 1996; (21):27-34. PubMed ID: 9023825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
    Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor prognosis in patients with adenosquamous cell carcinoma of the cervix.
    Gallup DG; Harper RH; Stock RJ
    Obstet Gynecol; 1985 Mar; 65(3):416-22. PubMed ID: 3974967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Invasive carcinoma of the cervix in young women in Tunisia].
    Maalej M; Daoud J; Messaad J; Frikha H; Benna F; Hechiche M; Rahal K; Ben Youssef R; Ben Romdhane K; Ben Abdallah M
    Bull Cancer Radiother; 1996; 83(3):158-63. PubMed ID: 8977566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of patients with stage IIIb-IVa squamous cell carcinoma of the cervix following intra-arterial neoadjuvant chemotherapy.
    Fujiwaki R; Maede Y; Ohnishi Y; Watanabe Y; Hata K; Miyazaki K
    J Exp Clin Cancer Res; 1999 Jun; 18(2):143-6. PubMed ID: 10464699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
    Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
    BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factors affecting patient survival in cervical cancer].
    Nugmanov EU
    Vopr Onkol; 1982; 28(4):76-8. PubMed ID: 6211833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival.
    Lea JS; Sheets EE; Wenham RM; Duska LR; Coleman RL; Miller DS; Schorge JO
    Gynecol Oncol; 2002 Jan; 84(1):115-9. PubMed ID: 11748986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage IB1 vs IB2 carcinoma of the cervix: should the new FIGO staging system define therapy?
    Grigsby PW
    Gynecol Oncol; 1996 Aug; 62(2):135-6. PubMed ID: 8751539
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
    Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
    Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influense of endogenous and exogenous factors on the development and prognosis of the cancer of the uterine cervix].
    Gatenadze TsZ; Sofrani MF; Dzhincharadze MI; Shotadze DT; Chakhoian OP
    Georgian Med News; 2009 Apr; (169):10-5. PubMed ID: 19430033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.